6 completed, 1 terminated. 7 Phase 1, 1 Phase 2.
By phase and status
Follow Experimental drug: new trials by email Literature Review of Experimental drug trials Research Report on Experimental drug
Trials (filtered) newest first · largest first
All 7 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
Evaluation of Vamorolone Mineralocorticoid Receptor Antagonism in Healthy Subjects Vamorolone, Eplerenone, Fludrocortisone - Pharmacodynamic | Phase 1 | Completed | 30 | 2024-06-05 | 2025-09-11 |
A First in Human Study of the Safety, Tolerability and Pharmacokinetics of PRV-002 in Healthy Volunteers PRV-002, Placebo - Traumatic Brain Injury (TBI) | Phase 1 | Completed | 40 | 2022-02-09 | 2024-11-04 |
NanoMn®_COVID-19 A Prospective, Multicenter, Randomized, Placebo-controlled, Parallel-group, Double-blind Trial to Evaluate the Clinical Efficacy of NanoManganese® on Top of Standard of Care, in Adult Patients With Moderate to Severe Coronavirus Disease 2019 (COVID-19) Placebo, Experimental drug - COVID-19 Pandemic | Phase 1 / Phase 2 | Terminated | 7 | 2022-02-04 | 2023-10-26 |
Clinical Trial to Assess the PK/PD of YYD601 20mg After Oral Administration if Healthy Adult Subjects (Phase1) YYD601 20mg, Nexium tab 20mg - GERD | Phase 1 | Completed | 28 | 2019-07-08 | 2021-05-11 |
Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment PF-05221304 - Hepatic Impairment | Phase 1 | Completed | 24 | 2017-12-19 | 2019-08-08 |
The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects YH4808, Nexium, Amoxicillin - Healthy | Phase 1 | Completed | 95 | 2013-07-01 | 2013-12-03 |
Study for Comparing The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg With Immediate Release Formulation and to Assess the Effect of High Fat Diet in Healthy Male Subjects Lyrica, Experimental drug, High fat meal - Healthy | Phase 1 | Completed | 30 | 2012-11-01 | 2014-09-01 |
Conditions studied
Brain Injuries, Traumatic (1) · COVID-19 (1) · Gastroesophageal Reflux (1) · Neuralgia (1)
Sponsors
IlDong Pharmaceutical Co Ltd (1) · Medesis Pharma SA (1) · Odyssey Group International, Inc. (1) · Pfizer (1) · Santhera Pharmaceuticals (1) · Yooyoung Pharmaceutical Co., Ltd. (1) · Yuhan Corporation (1)
Countries
South Korea (2) · Australia (1) · Belgium (1) · Brazil (1) · Czechia (1) · Germany (1) · Slovakia (1) · United States (1)
Top investigators
Philip Ryan, Dr. (1) · Steffen Haffner, MD (1)
Results publications
PMID 32274381, PMID 33062627, PMID 39803609, PMID 40957504
NIH funding
2017 (1)